| Filed On | Filing |
|---|---|
| 28 Feb 2025 |
Form 4/A: Arsenault Kaitlyn, Chief Financial Officer
Sold 190 shares ($1.05K) · Sold 43,026 shares ($215K) |
| 04 Mar 2024 |
Form 4/A: Arsenault Kaitlyn, Chief Financial Officer
Received 25,000 shares as a grant or award · Granted 75,000 Stock Option (Right to Buy) |
| 04 Mar 2024 |
Form 4/A: Dhillon Punit, Director
Received 100,000 shares as a grant or award · Granted 125,000 Stock Option (Right to Buy) |
| 31 Aug 2023 |
Form 4/A: Dhillon Punit, Director
Acquired 9,000 shares (Small Acquisition) ($106) · Received 20,277,414 shares as a grant or award · Granted 2,253,046 Stock Option (Right to Buy) · 2 more |
| 09 Jan 2023 |
Form 4/A: Tyle Praveen, Director
Granted 250,000 Stock Option (Right to Buy) |
| 13 Aug 2020 |
Form 4/A: Emerald Health Sciences Inc., 10% owner
Sold 2,566,666 shares ($257K) |
| 10 Nov 2014 |
Form 4/A: Mendez Francisco Javier, former Officer, Director, 10%
Disposed of 1,180,000 shares (Other Transaction) |
Loading...